Jubilant Ingrevia Ltd.
JUBLINGREA · NSE · Basic Materials
With a 20% margin of safety, our buy-below price is ₹418.75.
Piotroski F-score 5/9 — quality of earnings & balance sheet.
Investability checklist
- ✕ROE above 15%9.2%
- ✓Low debt (D/E < 0.5)0.25x
- ✓Positive free cash flow
- ✓Revenue growth > 10%12%
- ✓Earnings growing16%
- ✕Net margin ≥ 10%6.3%
- ✕Current ratio > 1.51.29
- ✕Below our fair value
- ✕Margin of safety ≥ 20%
- ✕Above 200-day average
- ✕Above 50-day average
- –Positive 1-year return
- ✓Altman Z in safe zoneZ 3.83
- ✕Piotroski ≥ 75/9
1-year price
EOD · 2026-06-15Our scores
Key fundamentals
SWOT snapshot
Strengths
- •Lightly leveraged balance sheet.
- •Financially solid — Altman Z 3.83.
Weaknesses
- •Price below its 200-day moving average (downtrend).
Opportunities
- •Earnings growing (16% YoY).
- •Revenue growing (12% YoY).
- •Trading in our value buy zone versus sector peers.
About Jubilant Ingrevia Ltd.
Jubilant Ingrevia Limited engages in life science products and solutions in India, the United States, Europe, China and internationally. The company operates in three segments: Specialty Chemicals, Nutrition & Health Solutions, and Chemical Intermediates. The Specialty Chemicals segment offers bio-pyridine and -picolines, fine chemicals, agro chemicals, custom development and manufacturing services, and microbial control solutions
More in Chemicals
Our verdict, fair value, financial-health and checklist are StocksWizard's own estimates, computed from public end-of-day data using standard models (DCF, relative valuation, Altman Z, Piotroski). For information only — not investment advice or a recommendation. Verify independently before investing.